- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 415/00 - Heterocyclic compounds containing the thiamine skeleton
Patent holdings for IPC class C07D 415/00
Total number of patents in this class: 24
10-year publication summary
|
0
|
0
|
2
|
0
|
0
|
2
|
0
|
3
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Innospec Limited | 410 |
3 |
| Janssen Pharmaceutica N.V. | 3162 |
2 |
| Daiichi Sankyo Company, Limited | 1890 |
2 |
| Ahammune Biosciences Private Limited | 10 |
2 |
| Compagnie générale des établissements Michelin SCA | 2718 |
1 |
| The General Hospital Corporation | 4871 |
1 |
| Agency for Science, Technology and Research | 3736 |
1 |
| Almac Discovery Limited | 63 |
1 |
| Biotie Therapies Corporation | 21 |
1 |
| Critical Outcome Technologies Inc. | 10 |
1 |
| East China University of Science and Technology | 552 |
1 |
| Guangzhou Insighter Biotechnology Co., Ltd. | 53 |
1 |
| Guangzhou Origmol Feed-additive Co., Ltd | 2 |
1 |
| Hetero Research Foundation | 172 |
1 |
| Shionogi & Co., Ltd. | 880 |
1 |
| University of Durham | 119 |
1 |
| Sironax LTD | 59 |
1 |
| Curasen Therapeutics, Inc. | 52 |
1 |
| Genesis Therapeutics, Inc. | 15 |
1 |
| Other owners | 0 |